EMPRA (EMPagliflozin and RAs in Kidney Disease)

NCT03078101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Kidney Disease
Diabetes Mellitus, Type 2
Chronic Kidney Disease stage3
Chronic Kidney Disease stage4

Interventions

DRUG: Empagliflozin 10 MG [Jardiance]
DRUG: Placebo Oral Tablet

Sponsor

Medical University of Vienna

Collaborators

[object Object]